Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shahenda M. El-Naggar"'
Autor:
Shaymaa E. Kassab, Samar Mowafy, Aya M. Alserw, Joustin A. Seliem, Shahenda M. El-Naggar, Nesreen N. Omar, Mohamed M. Awad
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 34, Iss 1, Pp 1062-1077 (2019)
Histone deacetylase 6 (HDAC6) is an attractive target for cancer therapeutic intervention. Selective HDAC6 inhibitors is important to minimise the side effects of pan inhibition. Thus, new class of hydroxamic acid-based derivatives were designed on s
Externí odkaz:
https://doaj.org/article/fab1d4b581ff43a6b0a728973da405bc
Autor:
Nesreen N. Omar, Shaymaa E. Kassab, Mohamed M Awad, Aya M. Alserw, Samar Mowafy, Joustin A. Seliem, Shahenda M. El-Naggar
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 34, Iss 1, Pp 1062-1077 (2019)
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry
Histone deacetylase 6 (HDAC6) is an attractive target for cancer therapeutic intervention. Selective HDAC6 inhibitors is important to minimise the side effects of pan inhibition. Thus, new class of hydroxamic acid-based derivatives were designed on s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40a722c3379c62ff8682d31fe806040c
https://doi.org/10.1080/14756366.2019.1613987
https://doi.org/10.1080/14756366.2019.1613987
Publikováno v:
International journal of oncology. 31(1)
Ovarian epithelial cancer is a significant cause of death among women, accounting for 5% of all female cancer-related fatalities. A lack of reliable detection methods and resistance to chemotherapy agents are considerable obstacles in the treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2ab4b7eb397871b42f8ddb914b454eb0
https://pubmed.ncbi.nlm.nih.gov/17549414
https://pubmed.ncbi.nlm.nih.gov/17549414
Autor:
Shahenda M El-Naggar
Publikováno v:
Journal of Endocrinology; Jul2007, Vol. 194 Issue 1, p179-191, 13p